Identification of novel therapeutics for complex diseases from genome-wide association data.

We specifically addressed these two issues in our reanalysis of this noisy data by - (a) Considering a series of four thresholds of decreasing stringency, starting with the highly significant threshold used in the original study, and decreasing to weakly significant(WS - p ≤ 10 -3 ).

also in 1,387 other papers